4512 — Wakamoto Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Wakamoto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,884	2,844	3,232	3,879	3,665
Net Total Accounts Receivable
Net Total Receivables	3,113	2,709	2,811	3,214	2,875
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8,648	7,638	8,608	9,353	8,970
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,648	3,527	3,297	3,032	3,028
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	15,983	14,572	14,953	15,712	15,421
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,435	1,713	2,009	2,239	1,808
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	4,036	3,187	3,473	3,805	3,395
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	11,947	11,386	11,481	11,907	12,026
Total Liabilities & Shareholders' Equity	15,983	14,572	14,953	15,712	15,421
Total Common Shares Outstanding